Therefore, CML cells could not drive cell proliferation following DAS-IAP treatment until sufficient amounts of BCR-ABL accumulate in the cells by de novo synthesis of the protein, which occasionally results in apoptosis of the cells (Fig. 6). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.